glucose 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
845 492-61-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • dextrose
  • D-Glucose
  • (+)-Glucose
  • glucose
  • dextrose monohydrate
  • anhydrous dextrose
  • glucose monohydrate
  • anhydrous glucose
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
  • Molecular weight: 180.16
  • Formula: C6H12O6
  • CLOGP: -2.21
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 5
  • TPSA: 110.38
  • ALOGS: 0.64
  • ROTB: 5
  • Status: OFP
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

PropertyValueReference
BA (Bioavailability) 99 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
Jan. 17, 1946 FDA B BRAUN

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug ineffective 388.84 9.83 775 111694 818558 49674097
Myelosuppression 297.33 9.83 244 112225 13273 50479382
Hypokalaemia 217.97 9.83 553 111916 87439 50405216
Rheumatoid arthritis 203.30 9.83 98 112371 202452 50290203
Hand deformity 202.83 9.83 4 112465 100195 50392460
Joint swelling 199.70 9.83 152 112317 245134 50247521
Systemic lupus erythematosus 199.07 9.83 36 112433 140586 50352069
Contraindicated product administered 190.72 9.83 48 112421 148910 50343745
Cardiac failure congestive 190.23 9.83 512 111957 83870 50408785
Glossodynia 169.26 9.83 27 112442 115542 50377113
Alopecia 162.62 9.83 183 112286 244864 50247791
Arthropathy 162.10 9.83 74 112395 157832 50334823
Hyperkalaemia 155.98 9.83 336 112133 47753 50444902
Hypervolaemia 146.20 9.83 228 112241 25271 50467384
Pneumonia 145.25 9.83 1379 111090 377022 50115633
Wound 139.49 9.83 32 112437 105762 50386893
Therapeutic product effect decreased 137.70 9.83 65 112404 135985 50356670
Colitis microscopic 131.57 9.83 112 112357 6408 50486247
Blood potassium decreased 130.11 9.83 267 112202 36678 50455977
Pericarditis 123.16 9.83 15 112454 78674 50413981
Pneumonia aspiration 118.67 9.83 232 112237 30772 50461883
Atrial fibrillation 116.14 9.83 491 111978 101254 50391401
Bone marrow failure 115.96 9.83 215 112254 27409 50465246
Pain 114.38 9.83 786 111683 578117 49914538
Arthralgia 112.66 9.83 547 111922 438155 50054500
Dehydration 111.43 9.83 648 111821 151801 50340854
Drug intolerance 111.15 9.83 198 112271 218906 50273749
Hypoxia 110.95 9.83 306 112163 50817 50441838
Pulmonary hypertension 107.78 9.83 233 112236 33184 50459471
Oedema peripheral 106.86 9.83 658 111811 157303 50335352
Lower respiratory tract infection 105.08 9.83 40 112429 95161 50397494
Respiratory failure 100.94 9.83 436 112033 90745 50401910
Acute kidney injury 99.98 9.83 856 111613 227202 50265453
Product use issue 99.74 9.83 111 112358 149364 50343291
Off label use 99.21 9.83 633 111836 473793 50018862
Infusion related reaction 96.49 9.83 142 112327 169415 50323240
Abdominal discomfort 95.87 9.83 235 112234 231406 50261249
Musculoskeletal stiffness 92.97 9.83 89 112380 128392 50364263
Discomfort 89.56 9.83 66 112403 108314 50384341
Acute respiratory failure 86.40 9.83 195 112274 28587 50464068
Sepsis 84.45 9.83 545 111924 132380 50360275
Swelling 83.72 9.83 203 112266 200669 50291986
Right ventricular failure 82.72 9.83 136 112333 15757 50476898
Helicobacter infection 81.51 9.83 8 112461 49694 50442961
Drug hypersensitivity 81.11 9.83 286 112183 250724 50241931
Glaucoma 76 9.83 130 112339 15556 50477099
Drug abuse 73.30 9.83 21 112448 59825 50432830
Gastrointestinal haemorrhage 73.16 9.83 340 112129 72981 50419674
Plasma cell myeloma 71.46 9.83 191 112278 31131 50461524
Pleural effusion 71.43 9.83 364 112105 81090 50411565
Rash 71.19 9.83 626 111843 436845 50055810
Hypotension 69.29 9.83 814 111655 234655 50258000
Pulmonary arterial hypertension 68.19 9.83 144 112325 20175 50472480
Cytokine release syndrome 66.76 9.83 89 112380 8545 50484110
Therapeutic product effect incomplete 66.64 9.83 63 112406 91452 50401203
Anaemia 66.63 9.83 855 111614 251601 50241054
Muscle injury 66.40 9.83 4 112465 37107 50455548
Gastrooesophageal reflux disease 63.87 9.83 337 112132 76091 50416564
Folliculitis 62.55 9.83 7 112462 39218 50453437
Maternal exposure during pregnancy 60.03 9.83 170 112299 159608 50333047
Treatment failure 59.78 9.83 136 112333 137501 50355154
Fluid retention 59.75 9.83 247 112222 50402 50442253
Pulmonary oedema 58.79 9.83 240 112229 48698 50443957
Hypersensitivity 58.76 9.83 262 112207 214899 50277756
Diverticulitis 55.31 9.83 181 112288 33001 50459654
Renal failure 55.20 9.83 416 112053 106217 50386438
Blood urea increased 54.99 9.83 145 112324 23440 50469215
Febrile neutropenia 54.55 9.83 388 112081 97279 50395376
Synovitis 52.50 9.83 124 112345 123741 50368914
Dyspnoea 52.15 9.83 1588 110881 546020 49946635
Hepatic enzyme increased 51.72 9.83 146 112323 137234 50355421
Asthenia 51.53 9.83 995 111474 318047 50174608
Non-cardiogenic pulmonary oedema 50.38 9.83 25 112444 556 50492099
Irritable bowel syndrome 49.86 9.83 26 112443 51415 50441240
Chronic obstructive pulmonary disease 49.09 9.83 242 112227 53193 50439462
Nasopharyngitis 49.08 9.83 241 112228 192686 50299969
Coma 49.03 9.83 253 112216 56626 50436029
International normalised ratio increased 48.99 9.83 208 112261 42944 50449711
Mental status changes 48.51 9.83 184 112285 36088 50456567
Diarrhoea 48.14 9.83 1676 110793 586800 49905855
Haemoglobin decreased 47.75 9.83 462 112007 126754 50365901
White blood cell count decreased 46.85 9.83 430 112039 116292 50376363
Blood bilirubin increased 46.60 9.83 167 112302 31871 50460784
Impaired healing 46.32 9.83 52 112417 69734 50422921
Deep vein thrombosis 45.55 9.83 299 112170 73005 50419650
Cardiac arrest 45.36 9.83 330 112139 83321 50409334
Renal ischaemia 44.49 9.83 23 112446 559 50492096
Injection site pain 44.03 9.83 115 112354 110909 50381746
Psoriatic arthropathy 43.79 9.83 25 112444 47007 50445648
Abortion spontaneous 43.72 9.83 19 112450 41753 50450902
Bronchitis 43.47 9.83 387 112082 103772 50388883
Hypoglycaemia 43.21 9.83 234 112235 53347 50439308
Ill-defined disorder 41.72 9.83 36 112433 54618 50438037
Electrolyte imbalance 41.51 9.83 107 112362 17062 50475593
Diabetes insipidus 40.48 9.83 37 112432 2327 50490328
PO2 increased 39.64 9.83 24 112445 798 50491857
Hyponatraemia 39.50 9.83 356 112113 95783 50396872
Injection site reaction 38.14 9.83 33 112436 49999 50442656
Oedema 38.13 9.83 277 112192 69904 50422751
Injection site bruising 38.04 9.83 17 112452 36751 50455904
Heparin-induced thrombocytopenia 37.19 9.83 45 112424 3920 50488735
Toxicity to various agents 36.27 9.83 300 112169 212199 50280456
Thrombocytopenia 36.00 9.83 438 112031 127235 50365420
Suicidal ideation 35.96 9.83 42 112427 55343 50437312
Injection site erythema 35.91 9.83 70 112399 74866 50417789
Atrial flutter 35.27 9.83 67 112402 8696 50483959
Blood magnesium decreased 35.04 9.83 77 112392 11083 50481572
Encephalopathy 34.84 9.83 158 112311 33553 50459102
C-reactive protein abnormal 33.60 9.83 10 112459 27799 50464856
Peritonitis bacterial 32.94 9.83 46 112423 4615 50488040
Decreased appetite 32.50 9.83 627 111842 200296 50292359
Intentional self-injury 32.49 9.83 6 112463 23106 50469549
Brain natriuretic peptide increased 32.48 9.83 45 112424 4482 50488173
PCO2 increased 32.44 9.83 24 112445 1119 50491536
Pregnancy 31.68 9.83 13 112456 29564 50463091
Injection site swelling 31.30 9.83 28 112441 41745 50450910
Cor pulmonale 31.27 9.83 29 112440 1858 50490797
Dementia 31.04 9.83 92 112377 15905 50476750
Hypernatraemia 30.11 9.83 52 112417 6269 50486386
Completed suicide 30.03 9.83 171 112298 131718 50360937
Arthritis 29.87 9.83 96 112373 86625 50406030
Blood alkaline phosphatase increased 29.65 9.83 163 112306 37363 50455292
Septic shock 29.53 9.83 223 112246 56952 50435703
Calcium deficiency 29.35 9.83 21 112448 929 50491726
Cardiomegaly 29.33 9.83 90 112379 15855 50476800
Full blood count decreased 28.76 9.83 112 112357 22234 50470421
Pancytopenia 28.53 9.83 299 112170 83731 50408924
Death 28.32 9.83 934 111535 324445 50168210
Intentional product use issue 28.01 9.83 83 112386 76835 50415820
Cardiac dysfunction 27.92 9.83 26 112443 1675 50490980
Psoriasis 27.71 9.83 71 112398 68929 50423726
Loss of personal independence in daily activities 27.43 9.83 73 112396 69977 50422678
Hypomagnesaemia 27.36 9.83 113 112356 23043 50469612
Acute left ventricular failure 27.34 9.83 19 112450 802 50491853
Wrong technique in product usage process 27.34 9.83 51 112418 55459 50437196
Hip arthroplasty 27.17 9.83 17 112452 30412 50462243
Hypovolaemia 27.15 9.83 63 112406 9402 50483253
Platelet count decreased 26.86 9.83 342 112127 100384 50392271
Infection 26.49 9.83 251 112218 172703 50319952
Product use in unapproved indication 26.45 9.83 150 112319 115669 50376986
Sinusitis 26.35 9.83 247 112222 170311 50322344
Transfusion 25.78 9.83 75 112394 12830 50479825
Haematocrit decreased 25.70 9.83 149 112320 34827 50457828
Prothrombin time prolonged 25.54 9.83 59 112410 8779 50483876
Headache 25.24 9.83 897 111572 505638 49987017
Vomiting 24.94 9.83 1257 111212 459501 50033154
Granulocytopenia 24.87 9.83 43 112426 5188 50487467
Bacteraemia 24.29 9.83 79 112390 14354 50478301
Blood bicarbonate decreased 24.06 9.83 30 112439 2695 50489960
Neutrophil count decreased 24.04 9.83 180 112289 45846 50446809
Metabolic alkalosis 24.01 9.83 30 112439 2701 50489954
Condition aggravated 23.95 9.83 491 111978 296567 50196088
Aspartate aminotransferase increased 23.48 9.83 271 112198 77727 50414928
Knee arthroplasty 23.47 9.83 27 112442 35819 50456836
Activated partial thromboplastin time prolonged 23.39 9.83 47 112422 6355 50486300
Ascites 23.32 9.83 148 112321 35713 50456942
Cardiogenic shock 23.27 9.83 82 112387 15517 50477138
Urinary tract infection 23.20 9.83 657 111812 223363 50269292
Atelectasis 23.05 9.83 91 112378 18179 50474476
Injection site pruritus 22.80 9.83 34 112435 40377 50452278
Tonsillar haemorrhage 22.52 9.83 11 112458 236 50492419
Failure to thrive 22.43 9.83 46 112423 6312 50486343
Oxygen consumption increased 22.21 9.83 33 112436 3503 50489152
Urine chloride decreased 22.07 9.83 8 112461 78 50492577
Red blood cell sedimentation rate increased 21.70 9.83 20 112449 29396 50463259
Electrocardiogram T wave peaked 21.30 9.83 10 112459 196 50492459
Respiratory distress 21.19 9.83 128 112341 30361 50462294
Therapeutic response decreased 21.03 9.83 46 112423 47185 50445470
Blood albumin decreased 20.98 9.83 71 112398 13165 50479490
Blood pressure decreased 20.93 9.83 203 112266 55706 50436949
Gastrointestinal disorder 20.68 9.83 124 112345 94332 50398323
Toxic epidermal necrolysis 20.66 9.83 97 112372 20895 50471760
Supraventricular tachycardia 20.59 9.83 69 112400 12732 50479923
Blood cholesterol increased 20.53 9.83 59 112410 55156 50437499
Product compounding quality issue 20.32 9.83 6 112463 28 50492627
Small intestinal obstruction 20.25 9.83 80 112389 15988 50476667
Mobility decreased 20.23 9.83 100 112369 79848 50412807
Blood potassium increased 20.15 9.83 81 112388 16317 50476338
Blood pH decreased 20.05 9.83 26 112443 2429 50490226
Sleep disorder 20.01 9.83 63 112406 57220 50435435
Pulse absent 19.65 9.83 37 112432 4769 50487886
Hypophagia 19.65 9.83 117 112352 27611 50465044
Oxygen saturation abnormal 19.59 9.83 27 112442 2675 50489980
Fatigue 19.52 9.83 1333 111136 706268 49786387
Cardiac failure acute 19.51 9.83 51 112418 8199 50484456
Generalised oedema 19.48 9.83 71 112398 13660 50478995
Urticaria 19.42 9.83 189 112280 129372 50363283
Cardiac failure 19.35 9.83 256 112213 75784 50416871
Blister 19.30 9.83 111 112358 85307 50407348
Mental status changes postoperative 19.28 9.83 9 112460 174 50492481
Dyspnoea exertional 19.17 9.83 186 112283 51047 50441608
Bezoar 19.09 9.83 19 112450 1329 50491326
Inflammation 18.90 9.83 64 112405 56848 50435807
Tachypnoea 18.71 9.83 73 112396 14504 50478151
Arrhythmia 18.70 9.83 132 112337 33000 50459655
Disability 18.65 9.83 3 112466 12772 50479883
Malnutrition 18.54 9.83 68 112401 13121 50479534
Blood pressure fluctuation 18.46 9.83 32 112437 35791 50456864
Torsade de pointes 18.34 9.83 63 112406 11772 50480883
Pulmonary embolism 18.02 9.83 322 112147 101382 50391273
Immune effector cell-associated neurotoxicity syndrome 17.77 9.83 17 112452 1133 50491522
Foetal death 17.77 9.83 49 112420 8131 50484524
Ventricular tachycardia 17.75 9.83 76 112393 15745 50476910
Hyperglycaemia 17.69 9.83 140 112329 36265 50456390
Atrioventricular block first degree 17.49 9.83 41 112428 6160 50486495
Product residue present 17.22 9.83 30 112439 3642 50489013
Urine sodium decreased 17.22 9.83 8 112461 153 50492502
Constipation 17.14 9.83 537 111932 185171 50307484
Coagulopathy 17.00 9.83 82 112387 17862 50474793
Inappropriate schedule of product administration 16.96 9.83 92 112377 71739 50420916
Drug reaction with eosinophilia and systemic symptoms 16.94 9.83 23 112446 28401 50464254
Metabolic encephalopathy 16.84 9.83 36 112433 5085 50487570
Foot deformity 16.78 9.83 11 112458 19199 50473456
Thyroid disorder 16.69 9.83 64 112405 12613 50480042
Joint stiffness 16.62 9.83 26 112443 30282 50462373
Blood chloride decreased 16.46 9.83 35 112434 4926 50487729
Catheter management 16.41 9.83 25 112444 2714 50489941
Blood creatinine increased 16.41 9.83 249 112220 75911 50416744
Thrombosis 16.36 9.83 193 112276 55640 50437015
Blood glucose increased 16.07 9.83 235 112234 71089 50421566
Clostridium difficile colitis 16.04 9.83 80 112389 17662 50474993
Blood potassium abnormal 15.89 9.83 22 112447 2190 50490465
Leukocytosis 15.82 9.83 95 112374 22484 50470171
Syncope 15.81 9.83 319 112150 102683 50389972
Serotonin syndrome 15.76 9.83 19 112450 24694 50467961
Disease progression 15.76 9.83 300 112169 95566 50397089
Neuropathy peripheral 15.63 9.83 302 112167 96455 50396200
Colitis 15.47 9.83 142 112327 38387 50454268
Hepatocellular injury 15.46 9.83 21 112448 25926 50466729
Confusion postoperative 15.45 9.83 8 112461 195 50492460
Acinetobacter sepsis 15.33 9.83 3 112466 0 50492655
Grip strength decreased 15.31 9.83 4 112465 12117 50480538
Skin dystrophy 15.24 9.83 5 112464 35 50492620
Chest pain 15.16 9.83 507 111962 176375 50316280
Exposure during pregnancy 15.14 9.83 184 112285 120831 50371824
Unresponsive to stimuli 15.03 9.83 118 112351 30491 50462164
Lethargy 14.98 9.83 172 112297 49260 50443395
Acute respiratory distress syndrome 14.93 9.83 89 112380 21010 50471645
Muscle spasticity 14.79 9.83 10 112459 17174 50475481
Pseudomonal bacteraemia 14.70 9.83 16 112453 1243 50491412
Chronic kidney disease 14.68 9.83 144 112325 39627 50453028
Oxalosis 14.55 9.83 5 112464 41 50492614
Multiple sclerosis relapse 14.48 9.83 48 112421 42916 50449739
Normal newborn 14.45 9.83 40 112429 6651 50486004
Accidental exposure to product 14.42 9.83 18 112451 23039 50469616
Tenosynovitis 14.31 9.83 3 112466 10562 50482093
Burkholderia test positive 14.20 9.83 8 112461 232 50492423
Drug eruption 14.17 9.83 19 112450 23587 50469068
Hypoalbuminaemia 14.00 9.83 51 112418 9809 50482846
Asthma 13.94 9.83 129 112340 89208 50403447
Cellulitis 13.93 9.83 228 112241 70570 50422085
Congestive hepatopathy 13.87 9.83 22 112447 2472 50490183
Incision site pain 13.86 9.83 14 112455 997 50491658
Oesophageal spasm 13.81 9.83 21 112448 2275 50490380
Posterior reversible encephalopathy syndrome 13.80 9.83 8 112461 14920 50477735
Infantile apnoea 13.67 9.83 13 112456 860 50491795
Bradycardia 13.63 9.83 210 112259 64216 50428439
Multiple drug therapy 13.52 9.83 19 112450 1918 50490737
Cerebrovascular accident 13.47 9.83 290 112179 94390 50398265
Injection site warmth 13.44 9.83 7 112462 13859 50478796
Posthaemorrhagic hydrocephalus 13.32 9.83 4 112465 20 50492635
Cholelithiasis 13.30 9.83 136 112333 37837 50454818
Device related sepsis 13.29 9.83 26 112443 3449 50489206
Catheter site extravasation 13.16 9.83 8 112461 268 50492387
Electrocardiogram abnormal 13.14 9.83 42 112427 7563 50485092
General physical health deterioration 13.12 9.83 230 112239 142204 50350451
Metabolic acidosis 13.10 9.83 138 112331 38687 50453968
Multiple allergies 13.07 9.83 45 112424 8418 50484237
Sinoatrial block 13.02 9.83 12 112457 763 50491892
Blood cholesterol decreased 13.00 9.83 12 112457 764 50491891
Alkalosis 12.92 9.83 8 112461 277 50492378
Pericardial effusion 12.76 9.83 99 112370 25490 50467165
Tendonitis 12.75 9.83 11 112458 16694 50475961
Pneumothorax spontaneous 12.69 9.83 11 112458 645 50492010
Chronic respiratory failure 12.65 9.83 17 112452 1645 50491010
Nodal arrhythmia 12.63 9.83 14 112455 1110 50491545
Transient ischaemic attack 12.57 9.83 118 112351 32092 50460563
Acne 12.57 9.83 15 112454 19580 50473075
Nail dystrophy 12.55 9.83 12 112457 799 50491856
Skin reaction 12.54 9.83 55 112414 11513 50481142
Cytotoxic oedema 12.40 9.83 6 112463 126 50492529
Vascular device infection 12.38 9.83 29 112440 4355 50488300
Red blood cell count decreased 12.24 9.83 122 112347 33713 50458942
Neonatal infection 12.11 9.83 6 112463 133 50492522
Hyperchloraemia 12.06 9.83 11 112458 690 50491965
Abortion incomplete complicated 12.05 9.83 3 112466 6 50492649
Cyst 12.04 9.83 6 112463 12181 50480474
Herpes zoster 12.02 9.83 100 112369 70686 50421969
Haemorrhage 12.00 9.83 176 112293 53265 50439390
Retinal ischaemia 11.96 9.83 8 112461 317 50492338
Catheter site haemorrhage 11.95 9.83 22 112447 2788 50489867
Mitral valve incompetence 11.92 9.83 73 112396 17398 50475257
Osteonecrosis of jaw 11.91 9.83 35 112434 32491 50460164
Central nervous system injury 11.91 9.83 6 112463 138 50492517
Product selection error 11.86 9.83 5 112464 75 50492580
Blood glucose decreased 11.74 9.83 75 112394 18136 50474519
Macular degeneration 11.70 9.83 63 112406 14325 50478330
Ataxia 11.65 9.83 61 112408 13725 50478930
Hyperdynamic left ventricle 11.64 9.83 6 112463 145 50492510
Hyperaldosteronism 11.61 9.83 7 112462 231 50492424
Vascular access malfunction 11.41 9.83 4 112465 35 50492620
Hepatitis 11.40 9.83 34 112435 31419 50461236
Serratia sepsis 11.40 9.83 5 112464 83 50492572
Atrioventricular block second degree 11.39 9.83 25 112444 3596 50489059
Paracentesis 11.32 9.83 12 112457 904 50491751
Disseminated intravascular coagulation 11.32 9.83 71 112398 17064 50475591
Orthopnoea 11.30 9.83 33 112436 5656 50486999
Unevaluable event 11.26 9.83 154 112315 45912 50446743
Infusion site necrosis 11.22 9.83 4 112465 37 50492618
Device difficult to use 11.16 9.83 4 112465 9882 50482773
Electrocardiogram U wave present 11.14 9.83 5 112464 88 50492567
Lung infiltration 11.14 9.83 59 112410 13334 50479321
Paraesthesia 11.13 9.83 194 112275 120049 50372606
Polyuria 11.11 9.83 38 112431 7083 50485572
Product substitution issue 11.04 9.83 9 112460 14048 50478607
Therapy cessation 11.04 9.83 26 112443 25985 50466670
Somnolence 11.01 9.83 435 112034 154550 50338105
Haemodynamic instability 10.97 9.83 41 112428 7983 50484672
Nodule 10.92 9.83 13 112456 16990 50475665
Stomatitis 10.88 9.83 159 112310 101185 50391470
Injection site rash 10.79 9.83 12 112457 16165 50476490
Blood aldosterone abnormal 10.77 9.83 4 112465 42 50492613
Oesophageal pain 10.76 9.83 21 112448 2781 50489874
Coeliac disease 10.72 9.83 3 112466 8682 50483973
Ischaemic hepatitis 10.71 9.83 17 112452 1912 50490743
Tachycardia 10.70 9.83 294 112175 99469 50393186
Product storage error 10.68 9.83 7 112462 12217 50480438
Oxygen saturation decreased 10.63 9.83 225 112244 73023 50419632
Gout 10.57 9.83 52 112417 11418 50481237
Ventricular fibrillation 10.55 9.83 49 112420 10510 50482145
Sedation 10.45 9.83 34 112435 30576 50462079
Emphysema 10.45 9.83 44 112425 9049 50483606
Fall 10.44 9.83 872 111597 334060 50158595
Pulmonary arterial pressure increased 10.40 9.83 23 112446 3325 50489330
Impaired work ability 10.39 9.83 9 112460 13631 50479024
Blindness cortical 10.36 9.83 8 112461 398 50492257
Hypercapnia 10.33 9.83 28 112441 4599 50488056
Osteoarthritis 10.30 9.83 100 112369 68506 50424149
Peptic ulcer 10.29 9.83 25 112444 3841 50488814
Vascular pseudoaneurysm 10.29 9.83 14 112455 1370 50491285
Potassium wasting nephropathy 10.29 9.83 4 112465 48 50492607
Oral herpes 10.24 9.83 19 112450 20706 50471949
Blood pressure diastolic abnormal 10.21 9.83 4 112465 9357 50483298
Splenic injury 10.14 9.83 6 112463 191 50492464
Weight increased 10.12 9.83 357 112112 201534 50291121
Oxygen therapy 10.10 9.83 16 112453 1796 50490859
Haemodialysis 10.03 9.83 41 112428 8321 50484334
Peripheral circulatory failure 10.02 9.83 9 112460 553 50492102
Supraventricular extrasystoles 9.97 9.83 25 112444 3919 50488736
Fibromyalgia 9.86 9.83 59 112410 44919 50447736
Vertigo 9.84 9.83 71 112398 51761 50440894

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug ineffective 139.79 10.25 429 70533 362741 29140824
Hypokalaemia 130.49 10.25 337 70625 49866 29453699
Drug abuse 124.44 10.25 21 70941 79862 29423703
Appendicolith 106.91 10.25 79 70883 3401 29500164
Cardiac failure congestive 103.17 10.25 410 70552 76171 29427394
Cardiogenic shock 91.74 10.25 165 70797 19025 29484540
Hypotension 70.90 10.25 745 70217 193609 29309956
Myelosuppression 67.42 10.25 112 70850 12115 29491450
Abdominal distension 63.55 10.25 248 70714 45663 29457902
Hyperkalaemia 60.85 10.25 300 70662 61092 29442473
Heparin-induced thrombocytopenia 58.77 10.25 66 70896 4913 29498652
Appendicitis 57.49 10.25 87 70875 8692 29494873
Sepsis 56.78 10.25 557 70405 142125 29361440
Blood potassium decreased 56.57 10.25 120 70842 15614 29487951
Hypervolaemia 56.49 10.25 128 70834 17417 29486148
Off label use 54.58 10.25 461 70501 300339 29203226
Ascites 54.12 10.25 202 70760 36417 29467148
Atrial fibrillation 48.32 10.25 425 70537 105221 29398344
Incision site pain 47.11 10.25 37 70925 1746 29501819
Treatment failure 47.02 10.25 15 70947 36924 29466641
Suicide attempt 43.16 10.25 14 70948 34096 29469469
Tachypnoea 42.92 10.25 105 70857 15010 29488555
Cytokine release syndrome 42.55 10.25 96 70866 13023 29490542
Stress 40.90 10.25 129 70833 21361 29482204
International normalised ratio increased 40.56 10.25 212 70750 44160 29459405
Rheumatoid arthritis 39.28 10.25 14 70948 32138 29471427
Therapeutic product effect incomplete 38.89 10.25 23 70939 39282 29464283
Multiple organ dysfunction syndrome 38.24 10.25 271 70691 62845 29440720
Oedema peripheral 38.13 10.25 398 70564 103159 29400406
Administration site extravasation 37.40 10.25 20 70942 482 29503083
Blood urea increased 37.38 10.25 150 70812 27962 29475603
Toxicity to various agents 35.19 10.25 258 70704 173403 29330162
Spinal muscular atrophy 35.02 10.25 16 70946 271 29503294
Injection site pain 35.01 10.25 17 70945 32429 29471136
Right ventricular failure 34.13 10.25 65 70897 7825 29495740
Lung consolidation 33.05 10.25 50 70912 4993 29498572
Pneumonia 32.01 10.25 999 69963 319173 29184392
Diaphragmatic spasm 31.43 10.25 11 70951 88 29503477
Burkholderia test positive 31.41 10.25 23 70939 976 29502589
Faecal volume decreased 29.82 10.25 11 70951 104 29503461
Cardiac failure 29.30 10.25 305 70657 78982 29424583
Bone marrow failure 28.51 10.25 136 70826 27313 29476252
Arthralgia 27.98 10.25 208 70754 139409 29364156
Soft tissue mass 27.95 10.25 18 70944 618 29502947
Mental status changes 27.32 10.25 160 70802 34767 29468798
Overdose 27.25 10.25 99 70863 79720 29423845
Haemoglobin decreased 27.02 10.25 387 70575 107988 29395577
Dehydration 25.98 10.25 403 70559 114345 29389220
Respiratory failure 25.89 10.25 351 70611 96780 29406785
Toxic epidermal necrolysis 25.86 10.25 99 70863 18054 29485511
Constipation 25.48 10.25 400 70562 113760 29389805
Drug interaction 25.26 10.25 328 70634 197057 29306508
Multimorbidity 25.11 10.25 16 70946 539 29503026
Lymphocyte count decreased 24.17 10.25 101 70861 19170 29484395
Gastrointestinal haemorrhage 23.97 10.25 294 70668 79239 29424326
Pulmonary hypertension 23.71 10.25 98 70864 18510 29485055
Dyspnoea 23.65 10.25 983 69979 325749 29177816
Acute respiratory failure 23.33 10.25 125 70837 26277 29477288
Fluid retention 23.22 10.25 115 70847 23445 29480120
Red blood cells urine positive 22.93 10.25 24 70938 1649 29501916
Pulmonary arterial hypertension 22.49 10.25 53 70909 7396 29496169
Serotonin syndrome 22.48 10.25 7 70955 17505 29486060
Headache 22.31 10.25 289 70673 173718 29329847
Asthenia 21.80 10.25 673 70289 214577 29288988
Drug reaction with eosinophilia and systemic symptoms 21.77 10.25 21 70941 27971 29475594
Intentional product misuse 21.59 10.25 31 70931 34630 29468935
Ventricular fibrillation 21.46 10.25 85 70877 15748 29487817
Ventricular tachycardia 21.41 10.25 109 70853 22465 29481100
Respiratory tract infection bacterial 21.31 10.25 15 70947 598 29502967
Atelectasis 21.16 10.25 83 70879 15309 29488256
Metabolic alkalosis 21.14 10.25 20 70942 1216 29502349
Superinfection 21.05 10.25 25 70937 1976 29501589
Drug resistance 20.75 10.25 13 70949 21527 29482038
Oesophageal perforation 20.67 10.25 16 70946 739 29502826
Plasma cell myeloma 20.54 10.25 156 70806 36959 29466606
Sputum increased 20.15 10.25 24 70938 1903 29501662
Oedema 20.13 10.25 166 70796 40317 29463248
Rales 20.09 10.25 51 70911 7459 29496106
Hyponatraemia 19.94 10.25 249 70713 67384 29436181
Psoriasis 19.90 10.25 29 70933 32198 29471367
Hypoxia 19.79 10.25 187 70775 47192 29456373
Product use in unapproved indication 19.58 10.25 125 70837 86750 29416815
Chills 19.13 10.25 258 70704 71042 29432523
Pneumococcal sepsis 18.74 10.25 16 70946 850 29502715
Hypernatraemia 18.56 10.25 49 70913 7337 29496228
Drug intolerance 17.86 10.25 58 70904 48321 29455244
Intentional self-injury 17.86 10.25 4 70958 12457 29491108
Sedation 17.48 10.25 10 70952 17395 29486170
Blood creatinine increased 17.42 10.25 294 70668 84808 29418757
Blood bilirubin increased 17.40 10.25 140 70822 33753 29469812
Acute kidney injury 17.35 10.25 790 70172 264477 29239088
Pulse absent 17.24 10.25 38 70924 5075 29498490
Increased bronchial secretion 17.04 10.25 20 70942 1561 29502004
Cardiac arrest 16.90 10.25 294 70668 85297 29418268
Vocal cord paralysis 16.55 10.25 15 70947 863 29502702
Pulmonary oedema 16.54 10.25 166 70796 42569 29460996
Renal tubular acidosis 16.51 10.25 21 70941 1782 29501783
Intentional product use issue 16.36 10.25 50 70912 42448 29461117
Interstitial lung disease 16.32 10.25 77 70885 57641 29445924
Suicidal ideation 16.29 10.25 37 70925 34679 29468886
Therapeutic product effect prolonged 16.28 10.25 9 70953 232 29503333
Cytomegalovirus infection 16.28 10.25 19 70943 23196 29480369
Disease complication 16.12 10.25 24 70938 2362 29501203
Hypoglycaemia 16.01 10.25 182 70780 48164 29455401
Musculoskeletal stiffness 15.94 10.25 42 70920 37416 29466149
Cardiomyopathy 15.89 10.25 74 70888 14713 29488852
Blood pressure fluctuation 15.38 10.25 15 70947 19879 29483686
Motor neurone disease 15.28 10.25 10 70952 353 29503212
Sensory integrative dysfunction 15.24 10.25 5 70957 32 29503533
Device related infection 15.18 10.25 76 70886 15560 29488005
Shoshin beriberi 15.14 10.25 6 70956 70 29503495
Aggression 15.01 10.25 40 70922 35501 29468064
Therapeutic product effect decreased 14.97 10.25 30 70932 29421 29474144
White blood cell count decreased 14.93 10.25 282 70680 83080 29420485
Cardiac dysfunction 14.91 10.25 20 70942 1787 29501778
Bacteraemia 14.91 10.25 78 70884 16245 29487320
Emotional disorder of childhood 14.86 10.25 5 70957 35 29503530
Joint swelling 14.75 10.25 65 70897 49565 29454000
Sopor 14.72 10.25 4 70958 10930 29492635
Loss of personal independence in daily activities 14.65 10.25 24 70938 25416 29478149
Epididymitis 14.57 10.25 22 70940 2193 29501372
Oesophagitis 14.57 10.25 62 70900 11861 29491704
Product use issue 14.33 10.25 69 70893 51375 29452190
Resuscitation 14.19 10.25 16 70946 1196 29502369
Endotracheal intubation 14.11 10.25 24 70938 2645 29500920
Blood glucose increased 14.04 10.25 209 70753 58775 29444790
Protein urine present 13.74 10.25 33 70929 4661 29498904
Infusion site necrosis 13.74 10.25 4 70958 16 29503549
Blood albumin decreased 13.67 10.25 60 70902 11635 29491930
Posthaemorrhagic hydrocephalus 13.50 10.25 6 70956 95 29503470
Pleural effusion 13.48 10.25 245 70717 71663 29431902
Cardiomegaly 13.40 10.25 67 70895 13709 29489856
Mobility decreased 13.33 10.25 26 70936 25754 29477811
Biliary obstruction 13.15 10.25 22 70940 2392 29501173
Obstructive airways disorder 13.11 10.25 5 70957 11011 29492554
Gastric ischaemia 13.03 10.25 3 70959 3 29503562
Product substitution issue 13.03 10.25 3 70959 9169 29494396
Visual acuity reduced 12.98 10.25 10 70952 14866 29488699
Swelling of eyelid 12.91 10.25 11 70951 583 29502982
Compartment syndrome 12.90 10.25 22 70940 2430 29501135
Drug dependence 12.84 10.25 19 70943 20962 29482603
Blood potassium increased 12.69 10.25 69 70893 14582 29488983
Angioedema 12.68 10.25 37 70925 31878 29471687
Myalgia 12.65 10.25 115 70847 73904 29429661
Ileus 12.59 10.25 68 70894 14334 29489231
Stoma closure 12.42 10.25 6 70956 116 29503449
Hypomagnesaemia 12.37 10.25 78 70884 17390 29486175
Cortical visual impairment 12.28 10.25 4 70958 25 29503540
Ventricular extrasystoles 12.15 10.25 54 70908 10528 29493037
Hyperinsulinaemia 12.07 10.25 5 70957 66 29503499
Product dose omission issue 11.99 10.25 161 70801 96222 29407343
Lung infiltration 11.97 10.25 58 70904 11721 29491844
Febrile neutropenia 11.88 10.25 353 70609 111887 29391678
Insomnia 11.88 10.25 146 70816 88615 29414950
Therapeutic response decreased 11.87 10.25 26 70936 24685 29478880
Platelet count decreased 11.85 10.25 332 70630 104340 29399225
Drug chemical incompatibility 11.82 10.25 3 70959 6 29503559
Lactobacillus test positive 11.77 10.25 4 70958 29 29503536
Intentional overdose 11.73 10.25 50 70912 38478 29465087
Product preparation error 11.64 10.25 17 70945 1645 29501920
Oropharyngeal pain 11.59 10.25 34 70928 29251 29474314
Skin warm 11.57 10.25 18 70944 1842 29501723
Pericardial fibrosis 11.54 10.25 4 70958 31 29503534
Clostridium difficile colitis 11.30 10.25 62 70900 13150 29490415
Mental impairment 11.13 10.25 4 70958 9137 29494428
Tumour lysis syndrome 11.11 10.25 64 70898 13820 29489745
Failure to thrive 11.02 10.25 42 70920 7642 29495923
Pantoea agglomerans infection 11.02 10.25 4 70958 36 29503529
Tachycardia 10.99 10.25 239 70723 72171 29431394
Carbon dioxide decreased 10.98 10.25 15 70947 1364 29502201
Metamyelocyte percentage increased 10.97 10.25 3 70959 9 29503556
Urine potassium increased 10.97 10.25 3 70959 9 29503556
Haematocrit decreased 10.87 10.25 112 70850 28910 29474655
Abdominal pain 10.84 10.25 412 70550 134945 29368620
Bilirubin conjugated increased 10.83 10.25 23 70939 2994 29500571
Disturbance in attention 10.74 10.25 22 70940 21402 29482163
Blood chloride decreased 10.67 10.25 25 70937 3476 29500089
Urticaria 10.66 10.25 82 70880 54578 29448987
Somnolence 10.61 10.25 160 70802 93795 29409770
Inappropriate schedule of product administration 10.52 10.25 63 70899 44409 29459156
Transplant failure 10.52 10.25 22 70940 2834 29500731
Alveolar lung disease 10.50 10.25 8 70954 361 29503204
Cardiac sarcoidosis 10.47 10.25 4 70958 42 29503523
Hospitalisation 10.44 10.25 66 70896 45922 29457643
Chest X-ray abnormal 10.39 10.25 26 70936 3768 29499797

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Myelosuppression 353.34 9.58 351 149275 23479 64325627
Drug ineffective 347.39 9.58 913 148713 839334 63509772
Hypokalaemia 293.97 9.58 779 148847 121124 64227982
Cardiac failure congestive 212.98 9.58 727 148899 129853 64219253
Hyperkalaemia 188.22 9.58 589 149037 100540 64248566
Drug abuse 187.85 9.58 39 149587 132335 64216771
Hypervolaemia 183.02 9.58 323 149303 37962 64311144
Rheumatoid arthritis 181.29 9.58 77 149549 164217 64184889
Joint swelling 173.22 9.58 147 149479 215235 64133871
Blood potassium decreased 140.58 9.58 298 149328 40101 64309005
Bone marrow failure 140.24 9.58 330 149296 47622 64301484
Pneumonia 137.33 9.58 1936 147690 557640 63791466
Sepsis 135.64 9.58 957 148669 229384 64119722
Off label use 132.73 9.58 892 148734 631914 63717192
Hand deformity 131.04 9.58 3 149623 62768 64286338
Arthropathy 129.78 9.58 59 149567 120908 64228198
Atrial fibrillation 127.18 9.58 754 148872 170335 64178771
Arthralgia 127.04 9.58 561 149065 441699 63907407
Hypotension 121.83 9.58 1385 148241 379589 63969517
Therapeutic product effect decreased 110.75 9.58 65 149561 115286 64233820
Appendicolith 109.51 9.58 79 149547 3390 64345716
Hypoxia 108.04 9.58 448 149178 87701 64261405
Colitis microscopic 107.43 9.58 108 149518 7324 64341782
Cardiogenic shock 105.73 9.58 233 149393 32194 64316912
Pulmonary hypertension 105.19 9.58 277 149349 42862 64306244
Oedema peripheral 104.14 9.58 839 148787 209478 64139628
Cytokine release syndrome 103.79 9.58 179 149447 20650 64328456
Systemic lupus erythematosus 98.17 9.58 29 149597 77583 64271523
Right ventricular failure 97.29 9.58 177 149449 21294 64327812
Respiratory failure 96.16 9.58 672 148954 160511 64188595
Contraindicated product administered 93.68 9.58 68 149558 107761 64241345
Acute respiratory failure 92.07 9.58 290 149336 49644 64299462
Dehydration 91.17 9.58 834 148792 215929 64133177
Heparin-induced thrombocytopenia 90.56 9.58 105 149521 8374 64340732
Wound 85.67 9.58 35 149591 76442 64272664
Pericarditis 85.46 9.58 20 149606 62496 64286610
Musculoskeletal stiffness 84.11 9.58 97 149529 123109 64225997
Blood urea increased 80.09 9.58 255 149371 43898 64305208
Drug intolerance 79.60 9.58 201 149425 187791 64161315
Toxicity to various agents 77.18 9.58 510 149116 363003 63986103
Alopecia 76.66 9.58 169 149457 165521 64183585
Acute kidney injury 76.34 9.58 1464 148162 447776 63901330
Gastrointestinal haemorrhage 75.03 9.58 545 149081 131767 64217339
Therapeutic product effect incomplete 74.46 9.58 78 149548 103404 64245702
Pulmonary arterial hypertension 73.53 9.58 174 149452 25193 64323913
Ascites 72.75 9.58 311 149315 61690 64287416
Pneumonia aspiration 72.42 9.58 301 149325 58970 64290136
International normalised ratio increased 71.54 9.58 368 149258 78799 64270307
Product use issue 70.80 9.58 154 149472 151561 64197545
Lower respiratory tract infection 70.72 9.58 69 149557 94545 64254561
Injection site pain 70.48 9.58 93 149533 111315 64237791
Glossodynia 70.24 9.58 31 149595 64665 64284441
Pain 69.45 9.58 887 148739 552624 63796482
Duodenal ulcer perforation 67.48 9.58 3 149623 34622 64314484
Haemoglobin decreased 64.37 9.58 714 148912 194349 64154757
Pleural effusion 63.73 9.58 507 149119 126052 64223054
White blood cell count decreased 63.16 9.58 601 149025 157236 64191870
Nasopharyngitis 62.86 9.58 238 149388 195835 64153271
Glaucoma 62.04 9.58 125 149501 16223 64332883
Fluid retention 60.93 9.58 287 149339 59319 64289787
Plasma cell myeloma 60.27 9.58 239 149387 45836 64303270
Drug hypersensitivity 59.79 9.58 316 149310 237499 64111607
Helicobacter infection 59.39 9.58 9 149617 38353 64310753
Mental status changes 57.84 9.58 288 149338 60874 64288232
Incision site pain 56.74 9.58 48 149578 2606 64346500
Pulmonary oedema 56.00 9.58 343 149283 78331 64270775
Febrile neutropenia 54.83 9.58 671 148955 186986 64162120
Infusion related reaction 54.43 9.58 197 149429 164270 64184836
Treatment failure 54.14 9.58 119 149507 116697 64232409
Cardiac arrest 53.62 9.58 570 149056 153494 64195612
Blood bilirubin increased 52.31 9.58 268 149358 57285 64291821
Dyspnoea 52.26 9.58 2099 147527 716575 63632531
Appendicitis 51.79 9.58 104 149522 13465 64335641
Tachypnoea 51.46 9.58 157 149469 26414 64322692
Sopor 50.71 9.58 5 149621 29656 64319450
Hypoglycaemia 50.21 9.58 369 149257 89523 64259583
Muscle injury 49.29 9.58 3 149623 26434 64322672
Injection site bruising 48.99 9.58 12 149614 36361 64312745
Oedema 48.31 9.58 372 149254 91563 64257543
Hyponatraemia 47.11 9.58 539 149087 147800 64201306
Intentional self-injury 46.88 9.58 6 149620 29038 64320068
Product use in unapproved indication 46.45 9.58 231 149395 176387 64172719
Abdominal distension 45.31 9.58 379 149247 95615 64253491
Psoriasis 44.18 9.58 61 149565 71642 64277464
Multiple organ dysfunction syndrome 44.00 9.58 393 149233 101020 64248086
Irritable bowel syndrome 43.67 9.58 16 149610 37353 64311753
Asthenia 43.53 9.58 1300 148326 426744 63922362
Intentional product use issue 43.49 9.58 98 149528 95266 64253840
Chronic obstructive pulmonary disease 43.37 9.58 298 149328 70750 64278356
Injection site swelling 43.05 9.58 21 149605 41332 64307774
Rash 42.65 9.58 778 148848 457771 63891335
Drug reaction with eosinophilia and systemic symptoms 42.32 9.58 38 149588 54179 64294927
Gastrooesophageal reflux disease 41.79 9.58 333 149293 82810 64266296
Suicidal ideation 41.62 9.58 56 149570 66486 64282620
Hypersensitivity 41.43 9.58 276 149350 196176 64152930
PO2 increased 40.43 9.58 31 149595 1461 64347645
Hypernatraemia 40.20 9.58 88 149538 12101 64337005
Atrial flutter 39.88 9.58 117 149509 19263 64329843
Abdominal discomfort 39.53 9.58 254 149372 182068 64167038
Discomfort 39.47 9.58 80 149546 80798 64268308
Atelectasis 39.40 9.58 146 149480 27120 64321986
Metabolic alkalosis 39.22 9.58 47 149579 3881 64345225
Headache 39.03 9.58 933 148693 528534 63820572
Injection site erythema 39.02 9.58 65 149561 70735 64278371
Ventricular tachycardia 38.75 9.58 170 149456 34095 64315011
Blood pressure fluctuation 38.55 9.58 38 149588 51833 64297273
Folliculitis 38.46 9.58 11 149615 30066 64319040
C-reactive protein abnormal 38.32 9.58 10 149616 29037 64320069
Bronchitis 38.13 9.58 403 149223 108340 64240766
Synovitis 38.11 9.58 111 149515 98979 64250127
Toxic epidermal necrolysis 38.01 9.58 179 149447 36987 64312119
Impaired healing 37.71 9.58 51 149575 60422 64288684
Diverticulitis 37.33 9.58 183 149443 38435 64310671
Non-cardiogenic pulmonary oedema 37.26 9.58 28 149598 1280 64347826
Therapeutic response decreased 36.79 9.58 40 149586 52148 64296958
Ill-defined disorder 36.68 9.58 29 149597 44023 64305083
Hepatic enzyme increased 36.47 9.58 166 149460 129777 64219329
Arthritis 35.92 9.58 89 149537 83725 64265381
Anaemia 35.79 9.58 1140 148486 377540 63971566
Administration site extravasation 35.46 9.58 25 149601 1034 64348072
Spinal muscular atrophy 35.17 9.58 16 149610 278 64348828
Renal failure 34.55 9.58 603 149023 181085 64168021
Psoriatic arthropathy 34.18 9.58 30 149596 43251 64305855
Lung consolidation 33.94 9.58 63 149563 7695 64341411
Hypomagnesaemia 33.93 9.58 174 149452 37202 64311904
Cardiac failure 33.87 9.58 462 149164 131911 64217195
Serotonin syndrome 33.81 9.58 25 149601 39257 64309849
Platelet count decreased 32.75 9.58 559 149067 167152 64181954
Renal ischaemia 32.68 9.58 24 149602 1059 64348047
Injection site reaction 32.64 9.58 36 149590 46628 64302478
Encephalopathy 32.58 9.58 241 149385 58578 64290528
Diabetes insipidus 32.50 9.58 46 149580 4475 64344631
Deep vein thrombosis 32.40 9.58 380 149246 104802 64244304
Red blood cell sedimentation rate increased 32.30 9.58 16 149610 31219 64317887
Inappropriate schedule of product administration 32.23 9.58 108 149518 92178 64256928
Ventricular fibrillation 32.19 9.58 125 149501 23735 64325371
Cardiomegaly 31.89 9.58 124 149502 23560 64325546
Cytomegalovirus infection 31.60 9.58 24 149602 37175 64311931
Diaphragmatic spasm 31.57 9.58 11 149615 90 64349016
Neutrophil count decreased 31.37 9.58 295 149331 76901 64272205
PCO2 increased 31.30 9.58 28 149598 1639 64347467
Pulse absent 31.12 9.58 66 149560 8880 64340226
Loss of personal independence in daily activities 31.00 9.58 77 149549 72377 64276729
Calcium deficiency 30.87 9.58 20 149606 718 64348388
Blood magnesium decreased 30.60 9.58 86 149540 13819 64335287
Cardiac dysfunction 29.12 9.58 36 149590 3070 64346036
Electrolyte imbalance 28.36 9.58 125 149501 25118 64323988
Pregnancy 27.87 9.58 7 149619 20858 64328248
Completed suicide 27.52 9.58 361 149265 224053 64125053
Blood potassium increased 27.20 9.58 126 149500 25854 64323252
Bacteraemia 27.07 9.58 129 149497 26782 64322324
Blood creatinine increased 27.02 9.58 454 149172 135328 64213778
Foetal death 27.01 9.58 49 149577 5881 64343225
Mobility decreased 26.96 9.58 105 149521 85735 64263371
Faecal volume decreased 26.78 9.58 11 149615 147 64348959
Blood albumin decreased 26.50 9.58 108 149518 20965 64328141
Aspartate aminotransferase increased 26.25 9.58 407 149219 119381 64229725
Sedation 25.82 9.58 35 149591 41427 64307679
Transfusion 25.70 9.58 96 149530 17898 64331208
Interstitial lung disease 25.58 9.58 128 149498 97604 64251502
Swelling 25.47 9.58 243 149383 159975 64189131
Constipation 25.31 9.58 704 148922 228633 64120473
Multimorbidity 25.20 9.58 20 149606 992 64348114
Brain natriuretic peptide increased 25.05 9.58 55 149571 7578 64341528
Cor pulmonale 24.92 9.58 27 149599 1998 64347108
Soft tissue mass 24.88 9.58 19 149607 890 64348216
Blood alkaline phosphatase increased 24.86 9.58 219 149407 56060 64293046
Full blood count decreased 24.75 9.58 111 149515 22471 64326635
Sinusitis 24.63 9.58 218 149408 145710 64203396
Failure to thrive 24.54 9.58 66 149560 10338 64338768
Osteonecrosis of jaw 24.41 9.58 34 149592 39791 64309315
Sleep disorder 24.35 9.58 65 149561 59644 64289462
Intentional product misuse 24.30 9.58 86 149540 72209 64276897
Urine chloride decreased 24.25 9.58 9 149617 90 64349016
Suicide attempt 24.18 9.58 84 149542 70923 64278183
Depressed mood 24.17 9.58 36 149590 40976 64308130
Tachycardia 23.46 9.58 482 149144 149097 64200009
Wrong technique in product usage process 23.40 9.58 75 149551 64899 64284207
Malnutrition 23.25 9.58 97 149529 19028 64330078
Abortion spontaneous 22.96 9.58 15 149611 25128 64323978
Blood glucose increased 22.95 9.58 337 149289 97736 64251370
Hepatocellular injury 22.71 9.58 44 149582 45191 64303915
Immune effector cell-associated neurotoxicity syndrome 22.62 9.58 29 149597 2566 64346540
Vomiting 22.57 9.58 1525 148101 549592 63799514
Generalised oedema 22.48 9.58 102 149524 20751 64328355
Infection 22.44 9.58 298 149328 184582 64164524
Inflammation 22.40 9.58 77 149549 65223 64283883
Cardiac failure acute 22.36 9.58 86 149540 16258 64332848
Ileus 22.31 9.58 109 149517 22857 64326249
Respiratory tract infection bacterial 22.08 9.58 17 149609 806 64348300
Vertigo 22.04 9.58 67 149559 58944 64290162
Urticaria 21.92 9.58 227 149399 147090 64202016
Chills 21.75 9.58 443 149183 136821 64212285
Thrombocytopenia 21.69 9.58 676 148950 223125 64125981
Hypovolaemia 21.61 9.58 82 149544 15404 64333702
Haematocrit decreased 21.28 9.58 207 149419 54448 64294658
Oxygen consumption increased 21.05 9.58 38 149588 4543 64344563
Catheter management 21.03 9.58 32 149594 3323 64345783
Peritonitis bacterial 20.96 9.58 57 149569 8986 64340120
Coma 20.87 9.58 302 149324 87313 64261793
Respiratory distress 20.77 9.58 199 149427 52132 64296974
Injection site pruritus 20.59 9.58 35 149591 37791 64311315
Drug resistance 20.50 9.58 31 149595 35071 64314035
Septic shock 20.41 9.58 351 149275 105086 64244020
Product substitution issue 20.28 9.58 8 149618 17853 64331253
Lung infiltration 20.19 9.58 99 149527 20790 64328316
Small intestinal obstruction 20.19 9.58 108 149518 23465 64325641
Tendonitis 20.07 9.58 11 149615 20271 64328835
Hyperglycaemia 20.00 9.58 223 149403 60745 64288361
Urinary tract infection 19.98 9.58 690 148936 230906 64118200
Acute left ventricular failure 19.76 9.58 20 149606 1367 64347739
Blood pH decreased 19.57 9.58 36 149590 4366 64344740
Granulocytopenia 19.57 9.58 61 149565 10379 64338727
Rheumatoid nodule 19.51 9.58 3 149623 12648 64336458
Blood chloride decreased 19.50 9.58 49 149577 7367 64341739
Herpes zoster 19.44 9.58 106 149520 79081 64270025
Supraventricular tachycardia 19.28 9.58 91 149535 18816 64330290
Alkalosis 18.82 9.58 12 149614 419 64348687
Product storage error 18.72 9.58 4 149622 13314 64335792
Knee arthroplasty 18.69 9.58 21 149605 26978 64322128
Oropharyngeal pain 18.64 9.58 125 149501 88742 64260364
Oesophageal perforation 18.59 9.58 17 149609 1024 64348082
Insomnia 18.54 9.58 335 149291 197501 64151605
Blood bicarbonate decreased 18.41 9.58 37 149589 4792 64344314
Aggression 18.35 9.58 51 149575 46181 64302925
Abdominal pain 18.08 9.58 892 148734 311483 64037623
Overdose 18.00 9.58 261 149365 159305 64189801
Posterior reversible encephalopathy syndrome 18.00 9.58 16 149610 22930 64326176
Gastrointestinal disorder 17.92 9.58 128 149498 89581 64259525
Burkholderia test positive 17.85 9.58 13 149613 566 64348540
Hip arthroplasty 17.85 9.58 14 149612 21337 64327769
Catheter site extravasation 17.81 9.58 11 149615 363 64348743
Coagulopathy 17.79 9.58 131 149495 31789 64317317
Prothrombin time prolonged 17.72 9.58 78 149548 15663 64333443
Maternal exposure during pregnancy 17.64 9.58 140 149486 95744 64253362
Electrocardiogram T wave peaked 17.52 9.58 15 149611 828 64348278
Diarrhoea 17.49 9.58 1923 147703 720781 63628325
Drug eruption 17.41 9.58 36 149590 36100 64313006
Lymphocyte count decreased 17.27 9.58 157 149469 40542 64308564
Obstructive airways disorder 17.21 9.58 17 149609 23168 64325938
Pneumococcal sepsis 17.13 9.58 18 149608 1286 64347820
Clostridium difficile colitis 17.09 9.58 115 149511 27108 64321998
Asthma 17.08 9.58 140 149486 95085 64254021
Syncope 16.85 9.58 482 149144 157153 64191953
Hepatitis 16.84 9.58 52 149574 45530 64303576
Red blood cells urine positive 16.70 9.58 34 149592 4444 64344662
Blood pressure decreased 16.69 9.58 287 149339 85912 64263194
Mental status changes postoperative 16.66 9.58 8 149618 158 64348948
Torsade de pointes 16.58 9.58 82 149544 17281 64331825
Muscle spasticity 16.55 9.58 9 149617 16660 64332446
Blood pressure increased 16.54 9.58 291 149335 172261 64176845
Cellulitis 16.43 9.58 307 149319 93350 64255756
Unresponsive to stimuli 16.38 9.58 184 149442 50209 64298897
Dementia 16.36 9.58 93 149533 20673 64328433
Dyspnoea exertional 16.33 9.58 251 149375 73479 64275627
Activated partial thromboplastin time prolonged 16.33 9.58 66 149560 12765 64336341
Renal injury 16.28 9.58 75 149551 15354 64333752
Osmotic demyelination syndrome 16.18 9.58 17 149609 1214 64347892
Condition aggravated 16.11 9.58 703 148923 371723 63977383
Body temperature decreased 16.03 9.58 22 149604 25906 64323200
Hyperpyrexia 16.00 9.58 36 149590 5041 64344065
Osteoarthritis 15.98 9.58 84 149542 63252 64285854
Haematotoxicity 15.97 9.58 5 149621 12891 64336215
Drug interaction 15.97 9.58 682 148944 361401 63987705
Epididymitis 15.92 9.58 20 149606 1734 64347372
Haemoptysis 15.90 9.58 179 149447 48869 64300237
Pneumonia staphylococcal 15.90 9.58 33 149593 4373 64344733
Cardiomyopathy 15.85 9.58 107 149519 25249 64323857
Drug chemical incompatibility 15.74 9.58 6 149620 65 64349041
Normal newborn 15.70 9.58 38 149588 5579 64343527
Fatigue 15.69 9.58 1510 148116 747220 63601886
Grip strength decreased 15.53 9.58 4 149622 11720 64337386
Anhedonia 15.49 9.58 68 149558 13638 64335468
Urine sodium decreased 15.43 9.58 9 149617 267 64348839
Renal tubular acidosis 15.36 9.58 26 149600 2953 64346153
Shoshin beriberi 15.34 9.58 6 149620 70 64349036
Device issue 15.26 9.58 18 149608 22630 64326476
Blood pressure systolic increased 15.20 9.58 61 149565 49392 64299714
Hypoalbuminaemia 15.16 9.58 81 149545 17593 64331513
Disturbance in attention 15.08 9.58 47 149579 41027 64308079
Pantoea agglomerans infection 15.04 9.58 6 149620 74 64349032
Resuscitation 14.94 9.58 21 149605 2030 64347076
Oesophageal pain 14.91 9.58 27 149599 3236 64345870
Accidental exposure to product 14.71 9.58 24 149602 26340 64322766
Tumour lysis syndrome 14.62 9.58 86 149540 19354 64329752
Disability 14.58 9.58 5 149621 12167 64336939
Unevaluable event 14.49 9.58 180 149446 50309 64298797
Device related infection 14.48 9.58 121 149505 30505 64318601
Arrhythmia 14.45 9.58 187 149439 52757 64296349
Oxygen saturation abnormal 14.39 9.58 28 149598 3543 64345563
Polyneuropathy 14.30 9.58 15 149611 19879 64329227
Middle insomnia 14.24 9.58 6 149620 12871 64336235
Paraesthesia 14.16 9.58 223 149403 134299 64214807
Cyanosis 14.15 9.58 94 149532 22061 64327045
Joint stiffness 14.05 9.58 31 149595 30373 64318733
Familial periodic paralysis 13.97 9.58 7 149619 152 64348954
Granulocyte count decreased 13.96 9.58 16 149610 1260 64347846
Blood pressure systolic abnormal 13.95 9.58 3 149623 9939 64339167
Hepatotoxicity 13.79 9.58 47 149579 39915 64309191
Chronic respiratory failure 13.78 9.58 23 149603 2583 64346523
Skin dystrophy 13.74 9.58 5 149621 47 64349059
Cardiovascular insufficiency 13.66 9.58 23 149603 2601 64346505
Congestive hepatopathy 13.46 9.58 29 149597 3944 64345162
Tonsillar haemorrhage 13.43 9.58 8 149618 247 64348859
Poor venous access 13.39 9.58 6 149620 12411 64336695
Oesophagitis 13.35 9.58 91 149535 21539 64327567
Gait disturbance 13.29 9.58 301 149325 171854 64177252
Rales 13.20 9.58 70 149556 15159 64333947
Blister 13.20 9.58 122 149504 80845 64268261
Oxygen therapy 13.16 9.58 21 149605 2272 64346834
Gastric ischaemia 13.13 9.58 3 149623 3 64349103
Electrocardiogram abnormal 13.11 9.58 64 149562 13417 64335689
Bradycardia 13.05 9.58 363 149263 117856 64231250
Oesophageal spasm 12.97 9.58 22 149604 2503 64346603
Left ventricular failure 12.95 9.58 46 149580 8371 64340735
Acne 12.89 9.58 21 149605 23060 64326046
Sputum increased 12.86 9.58 27 149599 3608 64345498
Cortical visual impairment 12.84 9.58 4 149622 22 64349084
Pulmonary arterial pressure increased 12.77 9.58 29 149597 4087 64345019
Impaired work ability 12.69 9.58 10 149616 15209 64333897
Hyperaldosteronism 12.67 9.58 9 149617 377 64348729
Decubitus ulcer 12.64 9.58 63 149563 13316 64335790
Hypophagia 12.62 9.58 144 149482 39443 64309663
Electrocardiogram U wave present 12.61 9.58 6 149620 116 64348990
Cardioactive drug level increased 12.56 9.58 26 149600 3439 64345667
Pain in extremity 12.51 9.58 575 149051 302510 64046596
Blood pressure diastolic abnormal 12.48 9.58 6 149620 11911 64337195
Multiple sclerosis relapse 12.48 9.58 51 149575 41084 64308022
Metabolic encephalopathy 12.47 9.58 44 149582 7981 64341125
Vascular device infection 12.42 9.58 37 149589 6143 64342963
Hot flush 12.41 9.58 60 149566 46175 64302931
Injection site warmth 12.34 9.58 8 149618 13454 64335652
Injection site rash 12.32 9.58 11 149615 15731 64333375
Confusion postoperative 12.27 9.58 7 149619 199 64348907
Alanine aminotransferase increased 12.17 9.58 415 149211 138616 64210490
Pericardial effusion 12.16 9.58 142 149484 39112 64309994
Hyponatraemic encephalopathy 12.14 9.58 8 149618 296 64348810
Disease complication 12.13 9.58 29 149597 4226 64344880
Pancytopenia 12.11 9.58 426 149200 142883 64206223
Nail dystrophy 12.09 9.58 12 149614 801 64348305
Myalgia 12.05 9.58 278 149348 158339 64190767
Epstein-Barr virus infection 12.03 9.58 7 149619 12481 64336625
Miosis 12.00 9.58 8 149618 13258 64335848
Stoma closure 11.95 9.58 6 149620 131 64348975
Abortion incomplete complicated 11.92 9.58 3 149623 6 64349100
Lactobacillus test positive 11.78 9.58 4 149622 30 64349076
Akathisia 11.75 9.58 6 149620 11504 64337602
Biliary obstruction 11.74 9.58 27 149599 3837 64345269
Thyroid disorder 11.72 9.58 56 149570 11636 64337470
Extrapyramidal disorder 11.68 9.58 17 149609 19535 64329571
Photosensitivity reaction 11.66 9.58 15 149611 18158 64330948
Mood swings 11.65 9.58 14 149612 17454 64331652
Electrocardiogram T wave amplitude decreased 11.63 9.58 10 149616 555 64348551
Motor neurone disease 11.63 9.58 9 149617 430 64348676
Blood potassium abnormal 11.51 9.58 21 149605 2531 64346575
Altered state of consciousness 11.49 9.58 47 149579 37855 64311251
Vocal cord paralysis 11.43 9.58 19 149607 2127 64346979
Skin disorder 11.39 9.58 30 149596 27650 64321456
Malaise 11.35 9.58 779 148847 395468 63953638
Foot deformity 11.25 9.58 13 149613 16491 64332615
Central nervous system injury 11.21 9.58 6 149620 150 64348956
Schizophrenia 11.13 9.58 6 149620 11162 64337944
Carbon dioxide increased 11.12 9.58 18 149608 1971 64347135
Splenic injury 11.09 9.58 7 149619 240 64348866
Lymphoedema 11.09 9.58 49 149577 9856 64339250
Injection site haemorrhage 11.02 9.58 25 149601 24253 64324853
Ventricular extrasystoles 10.97 9.58 74 149552 17455 64331651
Potassium wasting nephropathy 10.93 9.58 6 149620 158 64348948
Gout 10.88 9.58 86 149540 21327 64327779
HLA-B*27 positive 10.88 9.58 5 149621 89 64349017
Left ventricular dysfunction 10.87 9.58 72 149554 16882 64332224
Right ventricular dilatation 10.83 9.58 15 149611 1430 64347676
Basal cell carcinoma 10.82 9.58 36 149590 30802 64318304
Substance abuse 10.82 9.58 4 149622 9288 64339818
Arrhythmia supraventricular 10.81 9.58 17 149609 1816 64347290
Cognitive disorder 10.81 9.58 79 149547 55008 64294098
Multiple drug therapy 10.74 9.58 19 149607 2235 64346871
Oral herpes 10.73 9.58 22 149604 22130 64326976
Blood cholesterol increased 10.71 9.58 70 149556 49996 64299110
Lower gastrointestinal haemorrhage 10.70 9.58 62 149564 13877 64335229
Lip erosion 10.69 9.58 14 149612 1265 64347841
Weight increased 10.65 9.58 396 149230 212952 64136154
Haemodialysis 10.64 9.58 72 149554 17005 64332101
Blood aldosterone abnormal 10.60 9.58 4 149622 42 64349064
Catheterisation cardiac 10.59 9.58 30 149596 4843 64344263
Superinfection 10.56 9.58 26 149600 3860 64345246
Extravasation 10.53 9.58 23 149603 3157 64345949
Enterococcal bacteraemia 10.53 9.58 20 149606 2485 64346621
Chronic kidney disease-mineral and bone disorder 10.43 9.58 9 149617 502 64348604
Right atrial pressure increased 10.38 9.58 7 149619 269 64348837
Poisoning 10.37 9.58 22 149604 21857 64327249
Tuberculosis 10.34 9.58 9 149617 13029 64336077
Vasoplegia syndrome 10.31 9.58 21 149605 2746 64346360
Throat irritation 10.28 9.58 40 149586 32671 64316435
Oxalosis 10.26 9.58 5 149621 102 64349004
Bilirubin conjugated increased 10.23 9.58 30 149596 4938 64344168
Occult blood positive 10.22 9.58 35 149591 6252 64342854
Blood gases abnormal 10.21 9.58 12 149614 971 64348135
Blood sodium decreased 10.20 9.58 109 149517 29373 64319733
Therapeutic product effect prolonged 10.19 9.58 9 149617 518 64348588
Encapsulating peritoneal sclerosis 10.15 9.58 11 149615 814 64348292
Angioedema 10.14 9.58 93 149533 61728 64287378
Compartment syndrome 10.13 9.58 27 149599 4205 64344901
Hypercapnia 10.13 9.58 40 149586 7654 64341452
Deposit eye 10.13 9.58 4 149622 48 64349058
Dry eye 10.10 9.58 34 149592 28985 64320121
Alveolar lung disease 10.04 9.58 9 149617 528 64348578
Visual acuity reduced 10.00 9.58 31 149595 27110 64321996
Hyperinsulinaemia 9.99 9.58 6 149620 188 64348918
Paranoia 9.98 9.58 14 149612 16338 64332768
Electrocardiogram P wave abnormal 9.94 9.58 7 149619 289 64348817
Type IIa hyperlipidaemia 9.93 9.58 6 149620 190 64348916
Increased bronchial secretion 9.92 9.58 21 149605 2821 64346285
Frequent bowel movements 9.90 9.58 17 149609 18288 64330818
Mania 9.88 9.58 14 149612 16272 64332834
Azotaemia 9.87 9.58 39 149587 7463 64341643
Sensory integrative dysfunction 9.87 9.58 3 149623 15 64349091
Poisoning deliberate 9.84 9.58 10 149616 13448 64335658
Arteriovenous malformation 9.83 9.58 15 149611 1561 64347545
Vertebrobasilar insufficiency 9.82 9.58 6 149620 194 64348912
Stomatitis 9.82 9.58 187 149439 109418 64239688
Live birth 9.81 9.58 7 149619 11197 64337909
Food allergy 9.80 9.58 3 149623 7848 64341258
Protein urine present 9.80 9.58 44 149582 8912 64340194
Dystonia 9.77 9.58 18 149608 18847 64330259
Bezoar 9.77 9.58 18 149608 2185 64346921
Atrioventricular block first degree 9.76 9.58 50 149576 10684 64338422
Movement disorder 9.71 9.58 23 149603 21977 64327129
Gastritis erosive 9.65 9.58 46 149580 9549 64339557
Retroperitoneal haemorrhage 9.64 9.58 29 149597 4839 64344267
Electrocardiogram QT prolonged 9.64 9.58 247 149379 79201 64269905
Cardiomyopathy alcoholic 9.64 9.58 4 149622 55 64349051
Neutrophil count increased 9.63 9.58 95 149531 25079 64324027
Influenza like illness 9.62 9.58 94 149532 61608 64287498
Mitral valve incompetence 9.59 9.58 96 149530 25442 64323664

FDA Adverse Event Reporting System (Pediatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hyperglycaemia 32.07 29.88 12 282 80 84304

Pharmacologic Action:

SourceCodeDescription
ATC B05CX01 BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
IRRIGATING SOLUTIONS
Other irrigating solutions
ATC C05BB56 CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
ANTIVARICOSE THERAPY
Sclerosing agents for local injection
ATC V04CA02 VARIOUS
DIAGNOSTIC AGENTS
OTHER DIAGNOSTIC AGENTS
Tests for diabetes
ATC V06DC01 VARIOUS
GENERAL NUTRIENTS
OTHER NUTRIENTS
Carbohydrates
CHEBI has role CHEBI:75771 Mus musculus metabolites
CHEBI has role CHEBI:75772 S. cerevisiae metabolites
CHEBI has role CHEBI:76971 Escherichia coli metabolites
CHEBI has role CHEBI:77746 Homo sapiens metabolite
MeSH PA D005421 Flavoring Agents
MeSH PA D005503 Food Additives
MeSH PA D013549 Sweetening Agents
CHEBI has role CHEBI:78675 fundamental metabolites

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypoglycemia indication 302866003 DOID:9993




🐶 Veterinary Drug Use

SpeciesUseRelation
Cattle Dehydration associated with diarrhea Indication
Cattle Early treatment of scouring Indication
Cattle Followup treatment following intravenous fluid therapy Indication

🐶 Veterinary products

ProductApplicantIngredients
Re-Sorb, Vytrate Zoetis Inc. 6

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.87 acidic
pKa2 13.08 acidic
pKa3 13.91 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4019541 VUID
N0000147647 NUI
D00009 KEGG_DRUG
77938-63-7 SECONDARY_CAS_RN
50-99-7 SECONDARY_CAS_RN
1299920 RXNORM
4017760 VANDF
4019541 VANDF
C0017725 UMLSCUI
CHEBI:4167 CHEBI
BGC PDB_CHEM_ID
CHEMBL1222250 ChEMBL_ID
CHEMBL1614854 ChEMBL_ID
D005947 MESH_DESCRIPTOR_UI
DB09341 DRUGBANK_ID
4536 IUPHAR_LIGAND_ID
5793 PUBCHEM_CID
DB01914 DRUGBANK_ID
11133 MMSL
4567 MMSL
4787 MMSL
71873 MMSL
71874 MMSL
9763 MMSL
d00595 MMSL
000915 NDDF
002597 NDDF
111138002 SNOMEDCT_US
67079006 SNOMEDCT_US
725859007 SNOMEDCT_US
768547002 SNOMEDCT_US
LX22YL083G UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0264-1290 INJECTION, SOLUTION 70 g INTRAVENOUS UNAPPROVED DRUG OTHER 24 sections
Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0264-1510 INJECTION, SOLUTION 50 mg INTRAVENOUS NDA 24 sections
MYOCARD-DX HUMAN PRESCRIPTION DRUG LABEL 2 0264-1840 INJECTION 5 g INTRAVENOUS EXPORT ONLY 20 sections
MYOCARD-DX HUMAN PRESCRIPTION DRUG LABEL 2 0264-1880 INJECTION 5 g INTRAVENOUS EXPORT ONLY 20 sections
Isolyte P in Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0264-7730 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 23 sections
Dextrose in Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 5 0264-7751 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 22 sections
Theophylline in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9554 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 27 sections
Heparin Sodium in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9567 INJECTION 5 g INTRAVENOUS NDA 19 sections
Heparin Sodium in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9577 INJECTION 5 g INTRAVENOUS NDA 19 sections
Heparin Sodium in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9587 INJECTION 5 g INTRAVENOUS NDA 19 sections
Lidocaine Hydrochloride and Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9594 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 23 sections
Lidocaine Hydrochloride and Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9598 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 23 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0017 INJECTION, SOLUTION 50 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0023 INJECTION, SOLUTION 100 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0062 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0066 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0070 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0073 INJECTION, SOLUTION 2.50 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0074 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0077 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0078 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0081 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0082 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0085 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0089 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Lactated Ringers and Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0338-0125 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 18 sections
Dextrose and Electrolyte No. 48 HUMAN PRESCRIPTION DRUG LABEL 6 0338-0143 INJECTION 5 g INTRAVENOUS NDA 19 sections
Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0338-0551 INJECTION 5 g INTRAVENOUS NDA 21 sections
Potassium Chloride in Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 3 0338-0603 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Potassium Chloride in Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 3 0338-0663 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections